Hemab Therapeutics and Seaport Therapeutics are the newest biotech companies to join the public markets, each with an upsized IPO. According to IPO research firm Renaissance Capital, April was the biggest month for biotech IPO proceeds in more than five years.
The post Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five Years appeared first on MedCity News.
Microsoft Defender Mistakenly Flags DigiCert Root Certificates as Malware
Microsoft Defender triggered widespread false positive alerts after a faulty security update caused it to flag two legitimate DigiCert root certificates as malicious, potentially disrupting
